SCHEMBL6304885

SCHEMBL6304885

Cc1c(F)cc(-c2ccc(CNCCCN(C)C)cc2)c(F)c1F

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ CD274 Q9NZQ7 3/20 0.44
▸ PDCD1 Q15116 2/20 0.44
▸ TERT O14746 2/20 0.40
▸ CCNA2 P20248 1/20 0.40
▸ CDK2 P24941 1/20 0.40
▸ HRH4 Q9H3N8 1/20 0.40
▸ HRH3 Q9Y5N1 1/20 0.40
▸ LMNA P02545 1/20 0.39
▸ TSHR P16473 1/20 0.39
▸ CHRM2 P08172 2/20 0.38
▸ OPRM1 P35372 1/20 0.38
▸ OPRK1 P41145 1/20 0.38
▸ KDM4E B2RXH2 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ TMEM97 Q5BJF2 1/20 0.37
▸ SIGMAR1 Q99720 1/20 0.37
▸ PDCD1LG2 Q9BQ51 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4844832 0.88 CD274 (0.42) CD274PDCD1HRH4HRH3LMNA
SCHEMBL3537091 0.82 CD274 (0.41) CD274PDCD1HRH4HRH3LMNA
SCHEMBL4846945 0.78 SCN5A (0.45) —
SCHEMBL4713265 0.78 CD274 (0.42) CD274PDCD1HRH4HRH3CHRM2
SCHEMBL4847988 0.77 SCN5A (0.47) —
SCHEMBL25570588 0.76 CHRM2 (0.65) TERTCCNA2CDK2LMNACHRM2
SCHEMBL4848003 0.76 CYP2C19 (0.54) CD274LMNATSHRKDM4EHTT
SCHEMBL4846025 0.75 DPP7 (0.51) CD274PDCD1SIGMAR1
Tert-Butylamine SCHEMBL3542895 0.75 CD274 (0.38) CD274PDCD1HRH4HRH3LMNA
SCHEMBL3545636 0.74 DPP7 (0.50) CD274PDCD1HRH3SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6953803-B1 1-[(N-(2-(diethylamino)ethyl)-N-(4-(4-trifluoromethylphenyl)benzyl)aminocarbonylmethyl)]-2-(4-fluorobenzyl)thio-5-(1-methyl-4-pyrazolylmethyl)pyrimidin-4-one; enzyme inhibitors of lipoprotein associated phospholipase A2 (Lp-PLA2); atherosclerosis SMITHKLINE BEECHAM P.L.C. (GB) 2005-10-11 — — US disclosed
Send feedback